Objectives. To profile and compare the subgingival microbiome of RA patients with OA controls.
Introduction
Previous reports have implicated periodontitis in the aetiopathogenesis of RA [111] . Based on the high prevalence of periodontal dysbiosis in periodontitis, there has been interest in elucidating the role that specific microorganisms could play in the link between periodontitis and RA risk. Porphyromonas gingivalis, a Gram-negative anaerobe that is strongly associated with periodontitis, has perhaps garnered the most attention. Unique among prokaryotes, P. gingivalis expresses a peptidyl-arginine deiminase that catalyses protein citrullination [12] . This organism has further demonstrated the capacity to citrullinate proteins in vitro, generating antigens implicated in RA pathogenesis [13] . Recently, investigators have shown robust associations of antibody recognizing Aggregatibacter actinomycetemcomitans to RA risk, in addition to demonstrating that this organism induces hypercitrullination in host neutrophils generating a citrullinome paralleling that of the RA joint [14] . In another study, the subgingival presence of Prevotella and Leptotrichia species were overrepresented in treatment-naïve RA patients compared with healthy controls, irrespective of underlying periodontitis status [10] .
To date, most studies examining the role of periodontal pathogens in RA have been highly selective, examining either one or a limited number of pre-specified microbes [1, 3, 8] . Given inherent difficulties in culturing these organisms, most studies have also used serologic testing as surrogates of bacterial exposure. Thus, data generated using non-biased approaches to fully characterize the oral microbiome in RA are limited [10, 15] . In one such study, investigators characterized the subgingival microbiome samples from 65 RA patients [10] , while another used dental plaque to characterize the microbiome of 77 cases [15] . Using healthy controls for comparison, both studies demonstrated unique, but non-overlapping, microbiome characteristics specific to RA. To what degree other confounders such as smoking or sociodemographics might have contributed to these findings remains unclear.
Leveraging data and subgingival samples from a large, well-characterized casecontrol study, we characterized the microbiome of patients with established RA and diseased controls with OA [8] . We sought to identify whether RA patients harboured unique subgingival microbial signatures after accounting for the effects of other factors that could influence the oral microbiota, including periodontitis status. We hypothesized that patients with established RA would demonstrate a unique subgingival microbiome when compared with OA controls and that this difference would be independent of periodontitis status. If true, these results would inform future research strategies of RA treatment and/or prevention that could conceivably target specific oral pathogens.
Methods

Study participants and clinical assessments
Study subjects included participants in a multicentre casecontrol investigation examining the relationship of periodontitis with RA [8] . There were 617 study participants (287 RA cases and 330 OA controls) enrolled from from five participating centres. All cases satisfied the 1987 ACR classification criteria for RA with an age of disease onset >18 years [16] . OA in controls was based on medical documentation from a corresponding healthcare provider or imaging results consistent with degenerative arthritis. With demographics similar to cases, we used OA patients as comparators to minimize differences between RA cases and healthy control populations employed in other studies [10, 15] . The study was approved by the Institutional Review Board at each centre and all participants provided written informed consent prior to study enrolment.
Clinical assessments and sample collection
Cases and controls underwent a standardized and calibrated full mouth periodontal evaluation with periodontitis defined [17] . Subgingival plaque was collected from up to four mesiobuccal sites (one per quadrant) from posterior teeth from all but one participant (n = 616). Following removal of visible supragingival plaque, subgingival plaque samples were collected using a single sterile endodontic paper point for each site [18] . Up to four samples were pooled for each patient and frozen at À70 C until analysis. Serum was collected and RA cases were assessed for circulating concentrations of ACPA using a second-generation ELISA (Diastat, Axis-Shield; positivity 55 U/ml). RF (positive 515 IU/ml) and high-sensitivity CRP (mg/l) were determined by nephelometry (Siemens Healthcare Diagnostics, Tarrytown, NJ, USA). Disease activity in RA patients was quantified through the measurement of tender and swollen joint counts (028), and provider and patient global well-being scores (0100 mm visual analogue scales). A DAS-28-CRP was calculated [19] .
Subgingival microbiome identification
Genomic DNA was extracted from each subgingival sample using the Mobio Ultraclean Microbial DNA extraction kit (Carlsbad, CA, USA). For each sample, bacterial 16 S rRNA V1V3 gene segments were amplified in duplicate using composite 27 F (5 0 AGAGTTTGATCCTGG CTCAG 3 0 ) and 534 R (5 0 ATTACCGCGGCTGCTGG 3 0 ) primers. The forward and the reverse primers each contained unique barcodes to allow multiplex deep sequencing. Each 20 ml PCR contained 2 ml of the purified DNA template, 1Â Accuprime PCR buffer II, 0.2 mM of the forward primer, 0.2 mM of the reverse primer and 1.0 U of Accuprime Taq High Fidelity polymerase. PCR amplification was performed as follows: denaturation at 95 C for 2 min, followed by 25 cycles of denaturation at 95 C for 20 s, annealing at 56 C for 30 s and extension at 72 C for 5 min. The replicate barcoded PCR products for each sample were pooled and analysed on 1.5% SYBR Safe (Invitrogen, Carlsbad, CA, USA) agarose gel. Gel slices containing the amplicons of expected size ($600 bp) were excised and purified using the Qiagen gel extraction kit (Qiagen, Valencia, CA, USA). Purified PCR products were quantified using Qubit HS DNA quantification kit (Invitrogen, Carlsbad, CA, USA) and pooled with equal molar concentration. The use of barcodes allowed multiplexing and bidirectional sequencing on the Illumina MiSeq platform (Illumina, San Diego, CA, USA) in four pools, generating 16 145 880 raw reads. After trimming primer and barcode sequences and quality control, 11 039 494 V1V3 16 S rRNA gene sequence reads were available for analysis (averaging 19 855 ± 6809 reads per sample and an amplicon length of 487 nt). Good's coverage estimates were >0.95 for all samples. Rarefaction analysis indicates that sampling effort was sufficient for the majority of the samples, and further sampling would yield few additional taxa.
Paired-end raw Illumina sequence reads were joined using Fast Length Adjustment of Short reads (https://ccb. jhu.edu/software/FLASH/) and filtered with custom scripts written in R (https://www.r-project.org/) using the following quality criteria: minimum overlap of 10 bp from both paired ends, exact match to barcode and primer, no ambiguous bases and an average quality score of 30. Barcodes were variable lengths (48 bp) for each paired end and formed a unique combination for identification in each pool. In downstream analysis, the barcodes and primers (27 F and 534 R) were trimmed. Trimmed reads were then searched against the Human Oral Microbiome Database (HOMD; non-extended version 10.1) [20] and an HOMD sequence (full-length) was assigned for each read based on the best hit for that read. The tag matching of the V1V3 reads to full length HOMD sequences formed the basis of reference operational taxonomic unit (OTU), where the fulllength HOMD sequences and taxonomy information were used in the analysis. Reads with <80% alignable coverage and <97% identity were excluded from additional analysis.
Statistical analysis
Descriptive statistics including relative frequency for categorical variables and mean (S.D.) for continuous variables were calculated.
2 and non-parametric Wilcoxon rank sum tests were used to compare group characteristics. Sequencing data were filtered to exclude taxa for which >75% of patients in all four groups defined by RA-OA and periodontitis status had zero values. Alpha diversity indices were computed using the filtered data, and compared by group (RA-periodontitis, RA-no periodontitis, OA-periodontitis and OA-no periodontitis) via calculation of: total number of OTUs; Chao index, reflecting the total number of species (microbial richness); evenness, reflecting the relative abundance of species; Shannon diversity index, based on both evenness and richness (larger values reflecting more diverse microbiota); and Good's coverage estimator, reflecting the total percent of species represented. The Shapiro-Wilk test was used to assess normality. Based on the normality testing, Shannon index, evenness and Good's estimator were compared using the non-parametric Kruskal-Wallis test with Bonferroni's correction for pairwise comparisons. The number of OTUs and Chao index were compared using one-way analysis of variance with a Tukey-Kramer post hoc test used for pairwise comparisons. Additional analyses were undertaken to examine associations of RA-related factors including disease activity (DAS-28-CRP), disease duration and select medications (prednisone, MTX or biologics) with measures of microbial diversity. Using data limited to patients with RA, Pearson or Spearman correlations were calculated (as appropriate based on normality) to examine associations of the aforementioned alpha diversity indices with DAS-28-CRP and disease duration. Additionally, twosample t-tests or Wilcoxon rank sum tests were used as appropriate to compare indices among RA patients based on the use of prednisone, MTX or any biologic diseasemodifying agent.
Filtered raw count sequencing data were normalized with the method of trimmed mean of M-values and converted to log 2 -counts per million per sample by voom function built in the Linear Models for Microarray Analysis (limma) package in Bioconductor [2022] .
Two approaches were used to compare subgingival microbial communities by group. An unsupervised cluster analysis was completed and logistic regression models were generated to first examine prevailing microbiome patterns and associations with RA-OA status [23] . Specifically, hierarchical cluster analysis with averaging-linkage agglomeration on microbiome profiles was used to classify samples into clusters. Stepwise logistic regression was then used to identify variables associated with membership in clusters 1 vs 2, the two largest cluster memberships (or patient groups). The significance level for entry and removal of variables were set to be 0.05. RA vs OA disease status was retained in the model regardless of P-values. In addition to the presence of periodontitis, other factors examined included age, sex, selfreported race/ethnicity (Caucasian vs other), smoking status (ever vs never), BMI (kg/m 2 ), self-reported diabetes, education and marital status. A heat-map was generated to illustrate OTUs with at least a 2-fold difference in abundance between clusters 1 and 2 using Genesis 1.8.1 (Graz University of Technology, Graz, Austria).
Using a second approach, differential abundance analysis was conducted using the limma package [2022] . The analysis was conducted using two linear models: the first fitted with RA vs OA status, periodontitis status and their interaction (base model); and the second fitted with the same factors as in the base model in addition to race, marital status and smoking (fully adjusted model). The BejaminiHochberg method was used to control the false discovery rate to be no >0.05 for multiple hypotheses correction [24] . Principal component analysis plots were generated as an additional means of examining the associations of patient characteristics with subgingival micobiome composition. Microbial complexes (red, orange, yellow and purple) were defined according to Socransky et al. [25] , with red and orange complexes most closely linked to periodontitis while yellow and purple complexes have been more closely associated with oral health.
With reports of differential abundance of Haemophilus, Prevotella, Leptotrichia and possibly Aggregatibacter species in RA patients vs controls [10, 14, 15] , additional analyses explored differential abundance of P. gingivalis and other species at the genus level. In addition to P. gingivalis (OTU 619), OTUs including Haemophilus, Prevotella, Leptotrichia and Aggregatibacter were identified in filtered normalized data and median normalized counts were calculated for each of the four groups. A linear model was fitted with RA-OA disease status, periodontitis and the interaction of these, in addition to race, marital status and smoking.
Spearman correlations assessed the relationship between autoantibody (RF and anti-CCP) concentrations and normalized OTUs. To limit the possibility of type I error, autoantibody correlations were examined for OTUs based on prior reports suggesting associations of specific oral bacteria (P. gingivalis, Haemophilus and Aggregatibacter species, in addition to Anaeroglobus geminatus) with autoantibody expression [10, 14, 15, 26, 27] , as well as OTUs found in lower abundance between RA cases and OA controls.
Results
Of the 616 patients providing samples, 556 (90%) had sufficient DNA for sequencing. Characteristics for RA (n = 260) and OA (n = 296) patients are summarized in Table 1 . Compared with those with OA, patients with RA were more likely to be smokers, had lower BMIs and were less likely to have diabetes. As previously reported in the full cohort [10], RA patients included in this analysis were more likely to have periodontitis than OA patients (38% vs 27%, P = 0.007).
Alpha diversity indices across the four groups defined by RA-OA and periodontitis case status are shown in Table 2 . Although both OTU numbers and the Chao index were higher in those with periodontitis than those without, these were not significantly impacted by RA-OA status. There were no significant differences by group for the Shannon index, evenness or Good's coverage estimator. In additional analyses limited to RA patients, there were no correlations between the alpha diversity indices and DAS-28-CRP or disease duration, with the exception of a weak, but statistically significant, positive correlation between DAS-28-CRP and evenness (r = 0.15, P = 0.02). Likewise, we found no evidence of an association in RA patients between treatments received (prednisone, MTX or biologic) and microbial diversity (data not shown).
Hierarchical cluster analysis with averaging-linkage agglomeration on microbiome profiles was used to classify samples into one of seven unique clusters. The number of memberships of clusters 17 was 324, 223, 3, 2, 2, 1 and 1, respectively. With only nine patients with membership, clusters 37 were excluded from the further analysis. OTUs with >2-fold difference in abundance between clusters are shown (Fig. 1) . Bacteria comprising red and orange complexes [25] , thought to represent periodontitis pathogens, were generally found in greater abundance in clusters 2 vs 1. All three red complex bacteria (P. gingivalis, Tannerella forsythia and Treponema denticola) were found in 52-fold abundance in cluster 2 compared with cluster 1, as were two of three orange complex bacteria (Eubacterium nodatum and Streptococcus constellatus). Bacteria from the yellow and purple complexes, reflecting early colonizers and a healthier periodontium, were universally found in greater abundance in cluster 1 vs 2.
Using stepwise logistic regression, RA case status was not significantly associated with membership in clusters 1 vs 2 [odds ratio (OR) = 1.18; 95% CI: 0.80, 1.73] (Table 3) . Being married (OR = 1.57; 95% CI: 1.06, 2.33) and Caucasian race (OR = 1.94; 95% CI: 1.26, 2.99) were associated with an increased odds of membership in cluster 1 vs 2. In contrast, periodontitis (OR = 0.22; 95% CI: 0.15, 0.33) and ever smoking (OR = 0.65; 95% CI: 0.44, 0.96) were associated with a lower likelihood of membership in cluster 1.
Two principal components, PC1 (12.3%) and PC2 (8.9%), together explained 21.2% of the bacterial variation. Principal component analysis plots did not demonstrate evidence of clustering based on RA-OA case status, but showed variable degrees of clustering based on marital status, race, periodontitis and cigarette smoking (Fig. 2) .
Excluding taxa for which >75% of patients in all four groups had zero values, there were 286 OTUs available for analysis. Among those with periodontitis, there were 10 OTUs (3.5% of OTUs examined) in lower abundance in RA vs OA samples in the base model with false discovery rate-adjusted P-values. These taxa included Catonella (Table 4) . Results were unchanged following full adjustment, with the exception that differential expression of Selenomaonas sp. was no longer significant. Although we observed evidence to suggest the under-abundance of Porphyromonas sp. in RA patients with periodontitis compared with OA patients with periodontitis, there was not similar evidence of differential expression for P. gingivalis (data not shown). In subjects without evidence of periodontitis, only one OTU was found in lower abundance in RA samples and in the fully adjusted model after accounting for false discovery rate, Streptococcus sp. (OTU 486), a difference that did not With reports also showing associations of select pathogens with autoantibody expression in RA, we subsequently examined correlations of related OTUs with RF and anti-CCP antibody concentrations in RA patients (all patients and restricted to seropositive patients). We observed no significant correlations of A. geminatus or P. gingivalis, or with Haemophilus or Aggregatibacter containing OTUs with RF or anti-CCP antibody concentrations (data not shown). There were no associations of OTUs found in lower abundance in RA, shown in Table 4 , with autoantibody concentrations (data not shown).
Discussion
Using samples and data from a large casecontrol study, we explored links between oral bacteria and RA by profiling both the abundance and diversity of the subgingival microbiome in a large group of patients with established disease, using OA patients for comparison. Results from this study failed to support the existence of a robust subgingival microbial fingerprint that could reliably be used to discriminate RA patients from those with OA.
Scher et al.
[10] were among the first to deploy 16 S rRNA pyrosequencing to characterize subgingival microbial composition in RA. Using samples from treatmentnaïve patients (n = 31), patients with established RA (n = 34) and a smaller number of healthy controls (n = 18), the authors similarly observed no meaningful group differences referent to either microbial diversity or richness. The presence of periodontitis, more common in RA patients, was associated in our study with a higher number of OTUs and a higher Chao index (reflecting greater microbial richness). Similarly, Scher and colleagues found no evidence of microbial clustering based on RA case status, although the authors observed clustering based on the presence of moderate-to-severe periodontitis. In addition to replicating these results, we have extended these observations further by showing that other factors beyond the presence or absence of periodontitis appear to influence subgingival microbial composition. Subgingival samples from patients with a history of smoking, non-Caucasian race and those not married were more likely to segregate into a cluster characterized by an over-abundance of known pathogens. These results emphasize the importance of accounting for these factors in future research exploring the relationship between oral microbes and RA. Although others have also identified ethnic/racial background as a strong TABLE 2 Alpha diversity measures in patients with RA and OA with and without evidence of periodontitis Values satisfying normality assumption compared by group using ANOVA with Tukey-Kramer correction. Significant pairwise comparisons for the number of OTUs were: RA-periodontitis vs RA-no periodontitis (P = 0.04), OA-periodontitis vs RA-no periodontitis (P = 0.001) and OA-periodontitis vs OA-no periodontitis (P = 0.003); all other comparisons non-significant. Significant pairwise comparisons for the Chao index were: RA-periodontitis vs RA-no periodontitis (P = 0.05), OA-periodontitis vs RA-no periodontitis (P = 0.0008) and OA-periodontitis vs OA-no periodontitis (P = 0.001).
b
Values not satisfying normality assumption compared using Kruskal-Wallis test. OTU: operational taxonomic unit.
predictor of human microbiome composition [28] , mechanisms underpinning this association (as well as associations with other socioeconomic factors such as marital status observed in the present study) are unknown and warrant further study [29] . Demonstrating similar microbial composition across groups, Scher et al.
[10] identified Prevotella and Leptotrichia taxa in greater abundance in patients with untreated RA vs healthy controls independent of periodontitis. Using metagenomic shotgun sequencing of dental plaque samples, Zhang et al. [15] observed a decreased abundance of Haemophilus species and a simultaneous over-abundance of Lactobacillus salivarius in early RA patients vs controls. In contrast, we found a decreased subgingival abundance of OTUs including Prevotella in RA cases compared with controls.
FIG. 1 Heatmap demonstrating clusters 1 and 2 taxa
Results from these previous reports contrast with those from our study, which failed to identify an over-abundance of any taxa but identified an under-abundance of 10 different OTUs in RA patients relative to OA patients after accounting for periodontitis status and other factors. Of note, several of the OTUs identified to be in lower abundance have been implicated in periodontitis risk including Peptostreptococcus, Porphyromonas, Prevotella and Treponema species. Differences in the findings across studies may relate to the varied methods used (metagenomic shotgun sequencing vs 16 S rRNA 454 pyrosequencing vs Illumina sequencing) as well as the populations sampled. Although we failed to observe any significant associations of RA disease duration with microbial diversity in our study, marked differences in RA disease duration across studies could help to explain discrepancies in findings, with RA disease durations varying from a mean of just a few months [10] to >12 years in our study [8] . This difference may be particularly relevant as microbial dysbiosis reported to characterize untreated RA appears may be partially reversed with disease-modifying therapies [15] . Indeed, others found that red complex bacteria (T. forsythia and P. gingivalis) were present in greater abundance in the periodontium of early RA patients than in patients with established disease [10] . The authors speculated that this difference might have related to the effects of RA treatments, particularly agents shown to exert antimicrobial properties [30, 31] . Limited by its cross-sectional design, results from the present study do not support a major impact from treatments used, as we observed no associations of microbial diversity in RA patients with the use of prednisone, MTX or biologic The association of select oral microbes with RA risk has been hypothesized to be driven by bacterially mediated citrullination leading to the local expression of ACPA. Previous studies have shown associations, for instance, of circulating antibodies to P. gingivalis and, more recently, to A. actinomycetemcomitans [14] with ACPA. Using bacterial 16 S rRNA sequencing as a direct measure of subgingival bacterial exposure, we did not detect OTUs corresponding to the presence of A. actinomycetemcomitans, a pathogen that has been most closely associated with localized aggressive forms of periodontitis in younger individuals [32] , nor did we identify associations of P. gingivalis with ACPA. Separate studies performed in patients with early-onset disease yielded associations of alternative microbes, both Haemophilus species [15] and A. geminatus [10], with RA-related autoantibodies. Neither of these associations was replicated in the current study. It is possible that bacterially mediated ACPA production, if present, is more relevant in early disease, becoming less relevant over time as autoantibody production is established in other articular or extra-articular sites.
To date, several reports have examined the concept of targeting periodontitis as a means of treating RA. With its cross-sectional and observational study design, this investigation alone does not fully address questions about the relationship of subgingival microbiome composition with RA disease progression, recognizing the need for additional studies involving RA patients earlier in the disease process. Similarities in subgingival bacterial communities between established RA and OA in the present study as well as the lack of any robust associations between RA disease activity and measures of microbial diversity, however, do not support the concept of an intervention targeting specific subgingival pathogens in patients with established RA.
In summary, these results demonstrate that subgingival microbiome profiles in patients with established RA are similar to those observed in OA patients, and appear to be primarily influenced by other factors impacting oral health status. 
